Musculoskeletal conditions—including osteoarthritis, hip and elbow dysplasia, cruciate disease, and spondylosis—are among the most prevalent welfare-compromising conditions in dogs. Better detection, management, and preventive care significantly improve quality of life for affected dogs.
Osteoarthritis affects an estimated 20-35% of dogs at some point in their lives; prevalence increases dramatically with age. Yet studies consistently show significant under-recognition—owners often attribute pain-related behavioural changes to "slowing down with age" rather than treatable conditions. Improving owner awareness of pain signs and enabling proactive veterinary assessment represents a major quality of life improvement opportunity across the dog population.
Hip dysplasia (malformation of the hip joint) and elbow dysplasia (several developmental conditions causing elbow incongruity) are major sources of chronic pain and welfare compromise in predisposed breeds. Breeding schemes—BVA/KC Hip Scheme, BVA/KC Elbow Grading—use radiographic scoring to identify breeding animals with lower genetic risk. Progress in reducing dysplasia prevalence requires consistent breeder participation and selection pressure against high-scoring animals.
Cranial cruciate ligament rupture is the most common orthopaedic condition requiring surgery in dogs. Unlike in humans where traumatic rupture is typical, dogs more commonly experience progressive ligament degeneration causing gradual or sudden rupture. Surgical stabilisation (TPLO, TTA, lateral suture) achieves best outcomes in most dogs. Post-operative rehabilitation physiotherapy accelerates recovery. Obesity is a major preventable risk factor; weight management reduces cruciate disease risk and improves surgical outcomes.
Chronic musculoskeletal pain in dogs benefits from multimodal management: NSAIDs (meloxicam, grapiprant, carprofen) reduce inflammation; gabapentin addresses central sensitisation and neuropathic components; monoclonal antibody therapy (bedinvetmab targeting nerve growth factor) provides monthly anti-nerve growth factor analgesia; physiotherapy and hydrotherapy improve muscle support and joint health; weight management reduces joint loading; and environmental modifications reduce pain triggers.
Canine physiotherapy and rehabilitation has matured significantly, with qualified physiotherapists, hydrotherapy pools, and laser therapy available across the UK. Physiotherapy improves muscle mass, range of motion, and proprioception in arthritic dogs. Hydrotherapy provides low-impact exercise maintaining cardiovascular fitness and muscle tone without joint loading. These modalities complement pharmacological pain management and significantly improve welfare outcomes in chronically affected dogs.
Prevention strategies include: responsible breeding with health-tested parents; appropriate growth management in large breeds (avoiding high-caloric diets in puppyhood that accelerate growth beyond skeletal development capacity); maintaining lean body condition throughout life; appropriate exercise that builds muscle support without excessive joint loading; and regular veterinary health assessments that detect early joint changes before significant welfare deterioration.